SCHEMBL14899754

SCHEMBL14899754

CNS(=O)(=O)c1cc(C)ccn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 1/20 0.44
TNNI3K Q59H18 4/20 0.43
UHRF1 Q96T88 1/20 0.43
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
KDM4E B2RXH2 9/20 0.42
ALDH1A1 P00352 7/20 0.42
LMNA P02545 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
HPGD P15428 2/20 0.41
EGFR P00533 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24706909 0.79 TNNI3K (0.40) SMN1; SMN2GAATNNI3KKDM4EALDH1A1
SCHEMBL2643186 0.78 UHRF1 (0.48) SMN1; SMN2UHRF1CCR1CCR5CCR8
SCHEMBL3675739 0.76 KDM4E (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL1824530 0.76 UHRF1 (0.46) SMN1; SMN2UHRF1CCR1CCR5CCR8
SCHEMBL8434248 0.76 UHRF1 (0.46) SMN1; SMN2GAAUHRF1CCR1CCR5
SCHEMBL1464557 0.76 UHRF1 (0.46) SMN1; SMN2UHRF1CCR1CCR5CCR8
SCHEMBL30845679 0.76 KDM4E (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL4637636 0.75 LOXL2 (0.45) SMN1; SMN2LMNAHTT
SCHEMBL22954458 0.75 JAK2 (0.43) LMNA
SCHEMBL2642943 0.74 UHRF1 (0.45) SMN1; SMN2UHRF1CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 WO disclosed
WO-2021226458-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 WO disclosed
EP-2586778-A2 Pyridazinone derivatives useful as glucan synthase inhibitors Merck Sharp & Dohme Corp. (US) 2013-05-01 EP disclosed